- Records
- 19
- Recruiting
- 11
- Recruiting sites
- 613
- Countries
- 18
ClinicalTrials.gov registry snapshot / 2026-07-24Peptide trials,
Peptide trials,
without the maze.
Search every official registry record matched to 13 tracked peptide and next-generation weight-loss programs. Find current status, phase, enrollment, countries, US states, recruiting cities, postal areas, completion timing, and the direct NCT source.
268unique NCT records
13named programs
53countries represented
1,840recruiting cities
11registry result modules
Recruiting footprint by program
Study status is not drug rank.
Bar length shows registry-listed sites individually marked Recruiting. Larger programs can create larger counts. This does not compare efficacy, safety, approval odds, sponsor quality, or enrollment availability.
- Records
- 52
- Recruiting
- 10
- Recruiting sites
- 170
- Countries
- 7
- Records
- 37
- Recruiting
- 10
- Recruiting sites
- 73
- Countries
- 3
- Records
- 24
- Recruiting
- 10
- Recruiting sites
- 935
- Countries
- 28
- Records
- 27
- Recruiting
- 6
- Recruiting sites
- 1,581
- Countries
- 36
- Records
- 30
- Recruiting
- 5
- Recruiting sites
- 155
- Countries
- 6
- Records
- 8
- Recruiting
- 4
- Recruiting sites
- 339
- Countries
- 23
- Records
- 31
- Recruiting
- 3
- Recruiting sites
- 774
- Countries
- 34
- Records
- 15
- Recruiting
- 3
- Recruiting sites
- 3
- Countries
- 1
- Records
- 34
- Recruiting
- 2
- Recruiting sites
- 450
- Countries
- 27
- Records
- 9
- Recruiting
- 2
- Recruiting sites
- 4
- Countries
- 3
- Records
- 9
- Recruiting
- 1
- Recruiting sites
- 8
- Countries
- 1
- Records
- 5
- Recruiting
- 0
- Recruiting sites
- 0
- Countries
- 0
Official registry finder
Filter the exact records.
Search names, former codes, NCT IDs, sponsors, interventions, conditions, cities, and postal codes. Filtered URLs are shareable but intentionally excluded from search indexing so this page remains the canonical source.
9matching registry records
Matching recruiting site observations3
| Program and record | Status | Phase and enrollment | Locations | Primary completion | Registry update | Source |
|---|---|---|---|---|---|---|
| A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityNCT07243171 / Hangzhou Sciwind Biosciences Co., Ltd. | RecruitingVerified 2025-10 | Phase 1 / Phase 284 estimated | 1 matching recruitingBeijing, Beijing Municipality, 100029, China | Aug 3, 2026estimated | Jan 28, 2026ClinicalTrials.gov | Open NCT07243171 ↗ |
| A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure TherapyNCT07387094 / Hangzhou Sciwind Biosciences Co., Ltd. | RecruitingVerified 2026-01 | Phase 3140 estimated | 1 matching recruitingBeijing, Beijing Municipality, China | Dec 16, 2027estimated | Apr 14, 2026ClinicalTrials.gov | Open NCT07387094 ↗ |
| A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure TherapyNCT07434050 / Hangzhou Sciwind Biosciences Co., Ltd. | RecruitingVerified 2026-01 | Phase 3140 estimated | 1 matching recruitingShanghai, Shanghai Municipality, 200025, China | Jun 19, 2028estimated | Apr 13, 2026ClinicalTrials.gov | Open NCT07434050 ↗ |
| A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)NCT07073417 / Hangzhou Sciwind Biosciences Co., Ltd. | Active, not recruitingVerified 2025-07 | Phase 2163 actual | 0 matching recruitingNo city or postal detail is present for the matching registry rows. | Feb 27, 2027estimated | Apr 13, 2026ClinicalTrials.gov | Open NCT07073417 ↗ |
| A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DMNCT05680129 / Hangzhou Sciwind Biosciences Co., Ltd. | CompletedVerified 2023-07 | Phase 3623 actual | 0 matching recruitingNo city or postal detail is present for the matching registry rows. | Jul 3, 2024actual | May 8, 2025ClinicalTrials.gov | Open NCT05680129 ↗ |
| A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM PatientsNCT05680155 / Hangzhou Sciwind Biosciences Co., Ltd. | CompletedVerified 2023-07 | Phase 3211 actual | 0 matching recruitingNo city or postal detail is present for the matching registry rows. | Jun 12, 2024actual | Sep 10, 2025ClinicalTrials.gov | Open NCT05680155 ↗ |
| A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or ObesityNCT05813795 / Hangzhou Sciwind Biosciences Co., Ltd. | CompletedVerified 2024-07 | Phase 3664 actual | 0 matching recruitingNo city or postal detail is present for the matching registry rows. | Jun 20, 2024actual | Apr 30, 2025ClinicalTrials.gov | Open NCT05813795 ↗ |
| A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or DigoxinNCT06335134 / Hangzhou Sciwind Biosciences Co., Ltd. | CompletedVerified 2023-07 | Phase 157 actual | 0 matching recruitingNo city or postal detail is present for the matching registry rows. | Jan 8, 2024actual | May 8, 2025ClinicalTrials.gov | Open NCT06335134 ↗ |
| A Study of XW003 Injection in Chinese Adolescents With ObesityNCT07143227 / Hangzhou Sciwind Biosciences Co., Ltd. | CompletedVerified 2025-08 | Phase 148 actual | 0 matching recruitingNo city or postal detail is present for the matching registry rows. | Apr 18, 2026actual | May 20, 2026ClinicalTrials.gov | Open NCT07143227 ↗ |
Recruiting location footprint
Country and US state routes.
Counts are site observations across registry records, not unique facilities. The same research center can appear in multiple studies. Open the exact NCT record before treating a location as current.
Clinical trial finder FAQ
Status, location, and enrollment are different fields.
These answers prevent the most common registry-search errors before a reader follows an official source.
Are any Retatrutide clinical trials recruiting?
Yes. This 2026-07-24 snapshot contains 2 Retatrutide registry records with an overall Recruiting status and 450 listed sites individually marked Recruiting. Overall status does not mean every site is open, and neither status establishes eligibility or enrollment. Open the exact NCT record and verify the individual location before contacting a study team.
How do I find a peptide clinical trial near me?
Enter a city or postal code, optionally add a country or US state, and then open the exact ClinicalTrials.gov record. This finder retains location rows individually marked Recruiting but omits facility and personal contact fields. Confirm current recruitment, eligibility, official contact route, and travel requirements on the registry. Peptide Local does not enroll participants.
Does Recruiting mean I can join the trial?
No. Recruiting is a registry status, not an eligibility decision or appointment. A study can be recruiting overall while some listed locations are not yet recruiting, active but closed, completed, suspended, or missing a current site status. The study team applies the protocol's eligibility and consent process.
Are the drugs in this clinical trial finder FDA approved?
A ClinicalTrials.gov record is not FDA approval. The finder covers investigational programs and can also include studies involving components or comparators with separate regulatory histories. Approval must be verified on the exact FDA label or regulator record, not inferred from a phase, sponsor, trial result, or recruiting status.
Why do only some registry records show posted results?
11 of 268 records in this snapshot expose a ClinicalTrials.gov results module. A record without posted registry results can still have a publication or sponsor announcement elsewhere, while a posted module still requires careful interpretation. Results availability is not a quality rank.
How current is the peptide clinical trial data?
The registry data timestamp is July 24, 2026 at 9:00 AM UTC. The refresh workflow searches exact intervention names and aliases, deduplicates by NCT ID, preserves multi-program studies, and stores overall and individual-site status separately. Registry fields can change after that timestamp, so the direct source remains authoritative for enrollment decisions.
Evidence boundary
A registry finder, not an enrollment service.
A dated transformation of ClinicalTrials.gov intervention-search records for thirteen named Peptide Local pipeline programs. Study sponsors or investigators submit and maintain registry records. Overall status, individual-site status, enrollment, locations, completion dates, and results availability can change. Recruiting status does not establish eligibility, enrollment, treatment access, regulatory approval, routine availability, or a favorable benefit-risk conclusion.
Peptide Local omits personal contact details and does not screen participants, recommend a protocol, interpret eligibility, arrange treatment, or authenticate commercial products that reuse an investigational program's name.
Read the official API documentation ↗Understand evidence categories →